Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs BioAge Labs, Inc. (BIOA)

Aurora Cannabis Inc. and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. and BioAge Labs, Inc. are of similar size ($265.8M and $245.6M). Aurora Cannabis Inc. has the higher net margin (−38.1% vs −912.3%) and the higher return on invested capital (−5.58% vs −118.3%). Across the 16 metrics below, Aurora Cannabis Inc. leads on 9 and BioAge Labs, Inc. on 7.

Valuation

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.17 20.87 2.11
P/B 0.65 0.58 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.95 12.58
EV/Sales 0.93 (9.70) 2.73
Earnings yield (35.34%) (49.38%) (4.38%)
Free cash flow yield (14.67%) (112.36%) 0.00%

Profitability

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 100.00% 53.94%
Operating margin (12.13%) (1,026.28%) 0.00%
Net margin (38.12%) (912.25%) 0.00%
Free cash flow margin (17.19%) (2,345.11%) 0.00%
Return on equity (19.85%) (28.21%) (0.40%)
Return on assets (15.19%) (26.27%) (3.32%)
Return on invested capital (5.58%) (118.25%) 0.00%

Growth

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) — 10.01%
EPS growth (last fiscal year) (5,266.67%) 66.21% 49.06%
Revenue growth, 5-year CAGR 3.92% — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.05
Current ratio 5.36 17.19 2.31
Net debt to EBITDA 5.11 3.01 0.97

Dividend

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Market cap 265.84m 245.55m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack